3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Paediatric nuclear medicine practice: an international survey by the IAEA

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          The International Atomic Energy Agency (IAEA) decided to initiate a survey to evaluate the current status of the practice of paediatric nuclear medicine worldwide, with the focus mainly on low and middle-income countries specifically in Latin America, Eastern Europe, Africa and Asia. This investigation sought to determine if the practice in paediatric nuclear medicine in these countries differed from that indicated by the survey of the Nuclear Medicine Global Initiative (NMGI) and if nuclear medicine practitioners were following established paediatric nuclear medicine guidelines.

          Methods

          A total of 133 institutes took part in the survey from 62 different IAEA member states within Africa (29), Asia (39), Europe (29) and Latin America (36). The four most frequent conventional (single-photon) nuclear medicine procedures were 99mTc labelled MDP, DSMA, MAG3 and pertechnetate thyroid scans. In addition, 46 centres provided data on FDG PET/CT, including exposure data for the CT component. Nearly half of the sites (48%) perform less than 200 paediatric nuclear medicine studies per year, while 11% perform more than 1000 such studies per year.

          Results

          Administered activities largely exceeded the recommendations for most of the sites for DMSA, MAG3 and pertechnetate, while compliance with international standards was somehow better for MDP studies. For FDG PET, the results were more uniform than for conventional nuclear medicine procedures. However, the use of CT in PET/CT for paediatric nuclear medicine revealed a high variability and, in some cases, high, dose-length product (DLP) values. This observation indicates that further attention is warranted for optimizing clinical practice in FDG PET/CT.

          Conclusions

          Overall, in most parts of the world, efforts have been undertaken to comply either with the EANM dosage card or with the North American Consensus Guidelines. However, variability in the practice of paediatric nuclear medicine still exists. The results of this survey provide valuable recommendations for a path towards global standardization of determining the amount of activity to be administered to children undergoing nuclear medicine procedures.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: not found
          • Article: not found

          Pediatric radiopharmaceutical administered doses: 2010 North American consensus guidelines.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies.

            The lower detection rate of (18)F-FDG PET/MRI than (18)F-FDG PET/CT regarding small lung nodules should be considered in the staging of malignant tumors. The purpose of this study was to evaluate the outcome of these small lung nodules missed by (18)F-FDG PET/MRI.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011.

              A national survey of patient doses from 'whole-body PET-CT' examinations was conducted within all French nuclear medicine departments in 2011. Data related to injected [(18)F]-fluorodeoxyglucose (FDG) activity and to computerised tomography (CT) parameters were received from 56 positron emission tomography (PET)-CT units (answer rate: ∼60 %). The average specific injected FDG activity was equal to 4.3 MBq kg(-1), in agreement with European recommendations. The new 'time-of-flight' technology enabled to decreasing the specific activity down to 3.5 MBq kg(-1). The results have shown that current diagnostic reference levels (DRLs) for the diagnostic trunk CT are too high for CT combined with PET, only performed in France for attenuation correction and localisation, and not for diagnostic purpose. Despite wide variations between PET-CT units (4-fold factor in CTDI(vol)), DRLs equal to 8 mGy (CTDI(vol)) and 750 mGy cm (dose-length product) could be proposed for whole-body PET-CT. The average effective dose related to whole-body PET-CT examination in France has been assessed to ∼14 mSv.
                Bookmark

                Author and article information

                Contributors
                g.luca.poli@gmail.com
                Journal
                Eur J Nucl Med Mol Imaging
                Eur. J. Nucl. Med. Mol. Imaging
                European Journal of Nuclear Medicine and Molecular Imaging
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                1619-7070
                1619-7089
                8 December 2019
                8 December 2019
                2020
                : 47
                : 6
                : 1552-1563
                Affiliations
                [1 ]GRID grid.420221.7, ISNI 0000 0004 0403 8399, Dosimetry and Medical Radiation Physics Section, , International Atomic Energy Agency, ; Vienna, Austria
                [2 ]Department of Nuclear Medicine, DIC, CENTIS, Havana, Cuba
                [3 ]Medscan Nuclear Medicine and PET/CT Center, Concepcion, Chile
                [4 ]GRID grid.411760.5, ISNI 0000 0001 1378 7891, Department of Nuclear Medicine, , University Hospital Würzburg, ; Würzburg, Germany
                [5 ]GRID grid.2515.3, ISNI 0000 0004 0378 8438, Division of Nuclear Medicine, , Boston Children’s Hospital, ; Boston, Massachusetts USA
                Author information
                http://orcid.org/0000-0003-2144-6485
                Article
                4624
                10.1007/s00259-019-04624-w
                7188705
                31813051
                1eced12e-c93d-4957-8499-82d7d8921b96
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 13 November 2019
                : 18 November 2019
                Categories
                Original Article
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2020

                Radiology & Imaging
                international multi-centre survey,paediatric nuclear medicine,administered activity

                Comments

                Comment on this article